Clinical Trial Update: Anxiety Control by Erythrina Mulungu [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial assessed Erythrina mulungu extract for dental anxiety related to impacted third molar procedures; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dental Anxiety
• Third Molar Impaction

Drugs mentioned

• Erythrina mulungu extract (Erythrina mulungu)

Snippet

Sponsor: Liane Maciel de Almeida Souza | Conditions: Dental Anxiety, Impacted Third Molar Tooth | Phase 1, Phase 2 | Status: COMPLETED